Groove Botanicals, Inc.
GRVEOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$238572
P/E Ratio—
52W High$0.07
52W Low$0.0032
Groove Botanicals, Inc. (GRVE) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
GRVE · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 20, 2026EPS Actual
-$0.00
Revenue
—
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 20, 2026
After Market Close
GRVE reports quarterly as a OTC-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.03
Rev. $1.54B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.03
Rev. Est.$1.54B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 20, 2026 | — | -$0.00 | — | — | — | — |
| — Q4 FY2025 | Nov 19, 2025 | — | -$0.00 | — | — | — | — |
| — Q3 FY2025 | Aug 19, 2025 | — | -$0.00 | — | — | — | — |
| — Q3 FY2025 | Jul 15, 2025 | — | -$0.00 | — | — | — | — |
| — Q1 FY2025 | Feb 25, 2025 | — | -$0.00 | — | — | — | — |
| — Q4 FY2024 | Nov 14, 2024 | — | -$0.00 | — | — | — | — |
| — Q3 FY2024 | Aug 15, 2024 | — | -$0.00 | — | — | — | — |
| — Q1 FY2024 | Mar 31, 2024 | — | -$0.00 | — | — | — | — |
Q1 FY2026
Feb 20, 2026
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 19, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 19, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 15, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2025
Feb 25, 2025
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 14, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 15, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 31, 2024
EPS Actual
-$0.00
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for GRVE.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 20, 2026 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2025 | Nov 19, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2025 | Aug 19, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2025 | Jul 15, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q1 FY2025 | Feb 25, 2025 | — | $0.01 | $0.01 | +0.00% |
| — Q4 FY2024 | Nov 14, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q3 FY2024 | Aug 15, 2024 | — | $0.01 | $0.01 | +0.00% |
| — Q1 FY2024 | Mar 31, 2024 | — | No price data | $0.03 | — |
Q1 FY2026+0.00%
Report Date
Feb 20, 2026
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2025+0.00%
Report Date
Nov 19, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2025+0.00%
Report Date
Aug 19, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2025+0.00%
Report Date
Jul 15, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2025+0.00%
Report Date
Feb 25, 2025
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q4 FY2024+0.00%
Report Date
Nov 14, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q3 FY2024+0.00%
Report Date
Aug 15, 2024
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.01
Q1 FY2024—
Report Date
Mar 31, 2024
EPS Beat/Miss
—
Price Before
—
Price After
$0.03
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: GRVE ends December
Groove Botanicals, Inc. (GRVE) most recently reported earnings on February 20, 2026 for Q1 FY2026, posting EPS of $-0.00 (in line with the analyst consensus of —). The next GRVE earnings date is expected around September 1, 2026.
Each quarter, investors track GRVE earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GRVE revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
GRVE's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
GRVE earnings · 4 questionsGroove Botanicals, Inc.'s next earnings report is expected around September 1, 2026. GRVE typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GRVE historically reports after market close (AMC).
GRVE earnings datewhen is GRVE earningsGRVE next earnings datewhen does GRVE report earningsGRVE earnings calendar
▸ Source: FMP · Groove Botanicals, Inc. SEC filings · US GAAP · Groove Botanicals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026